https://patents.justia.com/assignee/polynovo-biomaterials-pty-limited
This is the link I have re PNV patents, no patent lawyer but am guessing that 25 years ( go with longer one for best case). Appears to me that current marketable BTM patents protection started in 2013. So we are 10 years already into the patent protection, best case scenario is PNV will have 15 years left to cement its position like COH and CSL.
Looking for genuine discussion (any lawyers or ppl familiar with patents). Don’t shoot the messenger, I would have like to have gotten to 4-6 SP today and had I have the benefit of hindsight yes I would have unloaded and go short. My goals are to make money not to be in love with a share and live in hope.
- Forums
- ASX - By Stock
- Patent
PNV
polynovo limited
Add to My Watchlist
2.09%
!
$1.22

https://patents.justia.com/assignee/polynovo-biomaterials-pty-lim...
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.22 |
Change
0.025(2.09%) |
Mkt cap ! $842.8M |
Open | High | Low | Value | Volume |
$1.19 | $1.26 | $1.19 | $2.833M | 2.297M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16695 | $1.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 8000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14807 | 1.220 |
1 | 82644 | 1.210 |
2 | 12200 | 1.200 |
3 | 123495 | 1.190 |
3 | 62102 | 1.185 |
Price($) | Vol. | No. |
---|---|---|
1.250 | 8000 | 1 |
1.265 | 201004 | 1 |
1.270 | 20000 | 1 |
1.280 | 3094 | 3 |
1.290 | 7717 | 3 |
Last trade - 16.11pm 04/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online